J. G. Bramness, K. Furu, S. Skurtveit et A. Engeland, « Effect of the market withdrawal of carisoprodol on use of other prescribed drugs with abuse potential », Clinical Pharmacology and Therapeutics, vol. 91, no 3, , p. 438–441 (ISSN1532-6535, PMID22318620, DOI10.1038/clpt.2011.250, lire en ligne, consulté le )
J. G. Bramness, K. Furu, S. Skurtveit et A. Engeland, « Effect of the market withdrawal of carisoprodol on use of other prescribed drugs with abuse potential », Clinical Pharmacology and Therapeutics, vol. 91, no 3, , p. 438–441 (ISSN1532-6535, PMID22318620, DOI10.1038/clpt.2011.250, lire en ligne, consulté le )
J. G. Bramness, K. Furu, S. Skurtveit et A. Engeland, « Effect of the market withdrawal of carisoprodol on use of other prescribed drugs with abuse potential », Clinical Pharmacology and Therapeutics, vol. 91, no 3, , p. 438–441 (ISSN1532-6535, PMID22318620, DOI10.1038/clpt.2011.250, lire en ligne, consulté le )
pubmed.ncbi.nlm.nih.gov
J. G. Bramness, K. Furu, S. Skurtveit et A. Engeland, « Effect of the market withdrawal of carisoprodol on use of other prescribed drugs with abuse potential », Clinical Pharmacology and Therapeutics, vol. 91, no 3, , p. 438–441 (ISSN1532-6535, PMID22318620, DOI10.1038/clpt.2011.250, lire en ligne, consulté le )